Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195757 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195897 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2023-06-26 | 2024-01-08 | 196362 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2024-04-11 | 2024-12-13 | 224901 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2024-09-05 | 2024-12-13 | 236816 |
| TEVA-TELMISARTAN HCTZ | 80.0MG 25.0MG | TABLET | Actual shortage | 2025-07-18 | 2025-12-12 | 263163 |
| TEVA-TELMISARTAN HCTZ | 80.0MG 25.0MG | TABLET | Actual shortage | 2025-11-13 | 2025-12-04 | 271799 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2022-01-20 | 2022-03-09 | 153135 |
| TEVA-TEMOZOLOMIDE | 140MG | CAPSULE | Resolved | 2022-01-27 | 2022-03-09 | 153706 |
| TEVA-TEMOZOLOMIDE | 100MG | CAPSULE | Resolved | 2022-03-04 | 2022-03-09 | 156061 |
| TEVA-TEMOZOLOMIDE | 5MG | CAPSULE | Resolved | 2022-06-09 | 2022-09-23 | 162268 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181628 |
| TEVA-TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2023-02-16 | 2023-04-28 | 184940 |
| TEVA-TEMOZOLOMIDE | 100MG | CAPSULE | Resolved | 2023-08-17 | 2025-08-08 | 202295 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2023-10-12 | 2025-09-04 | 206901 |
| TEVA-TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2023-10-19 | 2025-08-08 | 207542 |
| TEVA-TEMOZOLOMIDE | 140MG | CAPSULE | Actual shortage | 2024-01-11 | 2025-12-02 | 215734 |
| TEVA-TEMOZOLOMIDE | 5MG | CAPSULE | Actual shortage | 2024-02-08 | 2025-12-02 | 218986 |
| TEVA-TENOFOVIR | 300MG | TABLET | Resolved | 2020-07-30 | 2020-12-17 | 121509 |
| TEVA-TENOFOVIR | 300MG | TABLET | Resolved | 2022-02-17 | 2022-12-15 | 155186 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |